Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The application deadline for the 2024/25 High Cost Device List is now defined in England

In November 2022, NHS England defined a deadline for applications to the High Cost Device List (HCDL) changes to be implemented in the 2024/25 National Tariff Payment System.

Some High Cost devices (and drugs) are excluded from the calculation of prices under the National Tariff Payment System. These items are then either included in a fixed payment or paid in addition to the price of the related service. In 2022/23, all HCDL items were paid as add-on reimbursement.

To nominate a device to be added or removed from the 2024/25 HCDL, the application form should be completed and submitted to by May 31, 2023.

See more information here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).